Lineage Cell Therapeutics (LCTX) Depreciation and Depletion (2010 - 2016)
Lineage Cell Therapeutics (LCTX) reported Depreciation and Depletion of $248000.0 for Q3 2016, down 6.06% on a YoY basis from $264000.0 in Q4 2015, and down 22.26% quarter-over-quarter from $319000.0 in Q2 2016.
Lineage Cell Therapeutics (LCTX) Depreciation and Depletion (2010 - 2016) Analysis & Trends
Lineage Cell Therapeutics has reported Depreciation and Depletion for 7 years, with the latest figure at $248000.0 in Q3 2016.
- For the quarter ending Q3 2016, Depreciation and Depletion fell 6.06% year-over-year to $248000.0; the trailing twelve-month figure through Sep 2016 stood at $1.3 million (up 25.65% YoY), and the FY2015 full-year result was $1.1 million, up 2.57% from the prior year.
- Depreciation and Depletion for Q3 2016 stood at $248000.0, down from $319000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $429000.0 in Q1 2016, with the low at $88692.0 in Q1 2012.
- Historically, Depreciation and Depletion has averaged $217650.4 across 5 years, with a median of $249000.0 in 2015.
- Annual changes were most pronounced in 2012 — Depreciation and Depletion declined 24.75% — and 2014, when it jumped 134.71%.
- Lineage Cell Therapeutics' Depreciation and Depletion stood at $102820.0 in 2012, then jumped by 130.86% to $237370.0 in 2013, then gained by 8.27% to $257000.0 in 2014, then rose by 17.51% to $302000.0 in 2015, then declined by 17.88% to $248000.0 in 2016.
- The last three Depreciation and Depletion figures came in at $248000.0 (Q3 2016), $319000.0 (Q2 2016), and $429000.0 (Q1 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 248,000.00 |
| Sep 30, 2016 | 248,000.00 |
| Jun 30, 2016 | 319,000.00 |
| Jun 30, 2016 | 319,000.00 |
| Mar 31, 2016 | 429,000.00 |
| Mar 31, 2016 | 429,000.00 |
| Dec 31, 2015 | 302,000.00 |
| Dec 31, 2015 | 302,000.00 |
| Sep 30, 2015 | 264,000.00 |
| Sep 30, 2015 | 264,000.00 |
| Jun 30, 2015 | 249,000.00 |
| Jun 30, 2015 | 249,000.00 |
| Mar 31, 2015 | 263,000.00 |
| Mar 31, 2015 | 263,000.00 |
| Dec 31, 2014 | 257,000.00 |
| Dec 31, 2014 | 257,000.00 |
| Sep 30, 2014 | 271,000.00 |
| Sep 30, 2014 | 271,000.00 |
| Jun 30, 2014 | 266,055.00 |
| Jun 30, 2014 | 266,055.00 |